Noom Microdose is a GLP-1Rx program that pairs a low-dose compounded GLP-1 prescription with Noom's coaching and habit curriculum. Microdosed tirzepatide at Telos Rx is a narrower offer: provider-directed medication and clinical oversight, without a behavior course attached.
Both prescribe below the labelled range, but they are not the same product. One is a behavior-change company that added a prescription; the other is a provider service that added a lower dose. Our Telos Rx vs Noom comparison covers the general programs; this page is only about the microdose offerings.
What Noom's Microdose Program Actually Includes
Everything here comes from Noom's own published pages. Where Noom does not state something publicly, we say so.
Noom calls it the Noom Microdose GLP-1Rx Program, a low-dose GLP-1 approach aimed at reducing observable side effects, with a clinician adjusting the amount based on how your body responds.
On medication, Noom is explicit that the product is compounded rather than brand. Its disclosure states that compounded semaglutide available through the program is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality. Its microdose page also references tirzepatide offerings.
The bundle includes medication if prescribed, one-to-one coaching, a psychology-based curriculum, in-app logging and tracking, and the Noom GLP-1 Companion. Published eligibility is a BMI of 25 or higher, and availability is stated as all US states except Alabama, Louisiana and Mississippi.
What Microdosed Tirzepatide at Telos Rx Includes
Telos Rx offers compounded microdosed tirzepatide as a weekly subcutaneous protocol, with the amount personalized by the provider.
The service is online-first and asynchronous, and everything is subject to medical approval by a licensed provider. Telos Rx is LegitScript-certified, ships free within 48 hours if approved, accepts FSA and HSA, allows cancellation at any time, and covers all 50 states through licensed US compounding pharmacies, with formulation varying by state.
What it does not include is a coaching curriculum, the most useful difference to weigh before choosing.
Telos Rx vs Noom Microdose: Head to Head
Details reflect each company's published pages as of publication.
| Telos Rx microdosed tirzepatide | Noom Microdose GLP-1Rx | |
|---|---|---|
| Molecule | Tirzepatide, a dual GIP and GLP-1 receptor agonist | Compounded semaglutide named in its disclosure; page also references tirzepatide |
| Format | Compounded, supplied in a vial, weekly subcutaneous | Compounded; presentation not publicly listed |
| FDA status | Not FDA-approved; microdosing is not an FDA-approved use | States its compounded product is not FDA-reviewed for safety, efficacy, or quality |
| Who sets the amount | Prescribing provider, personalized to the individual | Clinician adjusts based on response, per its published pages |
| Coaching and habits | Not included | Central to the offer: one-to-one coaching, curriculum, logging and tracking |
| Published price | As low as $116 per month against a struck-through $279, flat as the dose is adjusted | $49 to get started, then $179 per month, recurring subscription |
| Stated eligibility | Determined by the reviewing provider from your intake | Published as a BMI of 25 or higher |
| Where available | All 50 states, formulation may vary by state | All US states except Alabama, Louisiana and Mississippi |
| Intake | Written asynchronous intake, no appointment, review often within hours | Short online assessment reviewed by a licensed clinician |
| Shipping | Free 48-hour shipping if approved | Home delivery; timeframe not publicly listed |
| FSA, HSA and cancellation | FSA and HSA accepted; cancel anytime | Not publicly listed on the microdose page |
The Molecule Difference Is the Real Difference
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both the GIP and GLP-1 receptors, which is why it is a dual agonist, though whether that matters at a reduced amount is unsettled by trial evidence. See microdosing tirzepatide vs semaglutide.
Why Both Programs Use Compounded Medication
This is structural, not a preference. The FDA-approved brands, Mounjaro for type 2 diabetes and Zepbound for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity, are supplied at fixed strengths. The Zepbound prescribing information lists set strengths in single-dose pens, single-dose vials and KwikPen presentations delivering preset amounts.
A fixed device cannot deliver an amount outside its own increments, which is why prescribing below the labelled range means compounded medication in a vial. The longer version: why microdosing tirzepatide requires compounding.
Compounded tirzepatide is not FDA-approved. It is prepared by licensed US compounding pharmacies under federal compounding regulations against a prescription for an individual patient. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, worth reading first.
If the medication and the provider relationship are what you are shopping for, rather than a habit curriculum, the Telos Rx microdose program is built around exactly that.
See microdosed tirzepatide at Telos RxCoaching Versus Clinical Care: Who Each One Suits
Noom is the better fit if the behavior side is your actual bottleneck. Noom built its business on psychology-led behavior change long before it prescribed anything, and that heritage is genuine. If eating patterns or accountability derailed previous attempts, bundling coaching with the prescription solves your real problem.
Telos Rx is the better fit if you want the clinical side handled and nothing bundled on top. If your routine is sorted, or you already work with a coach or trainer, paying monthly for a curriculum you will not open is a poor trade. Neither point is a criticism of the other: they are different products aimed at different bottlenecks.
What Neither Program Can Honestly Claim
Microdosing is not an FDA-approved concept. There is no approved microdose product and no approved microdose label, so there is no official definition of what amount counts as a microdose. It means prescribing below the standard labelled titration, at a provider's discretion. Anyone offering a precise universal threshold is inventing one.
The approved label starts at 2.5 mg weekly for four weeks, rises in 2.5 mg increments no sooner than every four weeks, and tops out at 15 mg weekly. That is the label, reported here as label information and not as guidance for you. If you came for a chart, read the tirzepatide dosage guide and what counts as a microdose, then ask a provider.
On evidence, be skeptical of both marketing decks. The pivotal trials, including SURMOUNT-1 in the New England Journal of Medicine, studied the labelled range in a defined trial population. No large randomized trial has established that microdosing produces comparable results. The rationale is pharmacological reasoning plus clinical experience, not phase 3 evidence, and microdosing has not been shown to be safer or superior to standard dosing.
Safety facts do not soften at a lower amount. Both Mounjaro and Zepbound carry a boxed warning for thyroid C-cell tumors in rodents, and both are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. See what changes with microdosing side effects and the tirzepatide side effects guide.
Pricing Transparency, Compared
Both publish a number, which puts them ahead of much of this market, but the structures differ. Noom's $179 per month bundles medication with coaching. The Telos Rx figure covers medication and clinical care only, so the two are not apples to apples. Decide whether you want the coaching first, then compare. Wider context: our tirzepatide cost guide.
How the Intake Works on Each Side
Noom describes a short online assessment reviewed by a licensed clinician. Whether a live consultation is required is not publicly listed.
Telos Rx is asynchronous by design: you complete a written intake and a licensed provider reviews it in writing, with no scheduled appointment. If microdosing is not suitable, the provider says so, and approval is never guaranteed. See also microdose vs standard tirzepatide and GLP-1 microdosing.
Frequently Asked Questions
What is the Noom microdose program?
Noom calls it the Noom Microdose GLP-1Rx Program: a low-dose compounded GLP-1 prescription bundled with one-to-one coaching, a psychology-based curriculum and in-app tracking. A licensed clinician reviews a short online assessment and adjusts the amount based on response. Noom states the product is not FDA-reviewed for safety, efficacy, or quality.
Does Noom microdose use semaglutide or tirzepatide?
Noom's microdose disclosure names compounded semaglutide, and its microdose page also references compounded semaglutide and tirzepatide offerings. Which molecule an individual is offered is not publicly listed. The Telos Rx microdose program is tirzepatide specifically, a dual GIP and GLP-1 receptor agonist rather than a GLP-1 agonist alone.
How much does Noom Microdose GLP-1Rx cost?
As of publication, Noom's microdose page publishes $49 to get started, then $179 per month on a recurring subscription, covering medication if prescribed plus coaching. Telos Rx publishes microdosed tirzepatide as low as $116 per month against a struck-through $279, for medication and clinical care. Both can change.
Is microdosing GLP-1 medication FDA-approved?
No. There is no FDA-approved microdose product and no approved microdose label, so there is no official definition of what counts as a microdose. It means prescribing below the standard labelled titration at a provider's discretion. Compounded tirzepatide is also not FDA-approved, placing a compounded microdose outside the approved framework twice over.
Is Telos Rx or Noom better for microdosing?
It depends what you need. Noom is the stronger choice if structured behavior change and coaching are what previous attempts lacked, because that is what the company was built to do. Telos Rx is the stronger choice if you want tirzepatide specifically, asynchronous provider care and flat pricing.
Can I get microdosed tirzepatide without an appointment?
Telos Rx operates as an online-first, asynchronous telehealth service, so there is no scheduled appointment. You complete a written intake and a licensed provider reviews it, often within hours. It remains a prescription medication throughout, subject to medical approval by a licensed provider, and approval is not guaranteed.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
If the microdose route is what you want to explore, start with the microdosed tirzepatide page for current pricing, then complete the written intake: start an online visit for microdosing. A licensed provider reviews every request, and approval is not guaranteed.